Research on disease-causing bacteria and how they spread. Covers waterborne bacteria, Lyme disease ecology, pathogenic genetics, and biofilm treatments.
A new device called the BioSampler detects airborne pathogens more accurately than traditional methods, even in low concentrations. The BioSampler causes less damage to microorganisms, allowing for a more accurate assessment of their viability and potential threat to human health.
Researchers have found the same plasmids responsible for antibiotic resistance in common bacteria also present in the plague bacillus Yersinia pestis, raising concerns about its potential spread. This discovery highlights a significant public health risk as MDR Y. pestis could rapidly evolve and affect human health.
Scientists have detailed images of a bacterial cell wall target that could aid in designing new antibiotics to treat deadly infections. The images, published in the journal Science, show an antibiotic called moenomycin binding to the enzyme, providing a new understanding of its structure and function.
Researchers found that more than half of primitive organisms have acquired genes through horizontal gene transfer, while only a few eukaryotes have done so. Two species of bacteria were also found to share large groups of genes, allowing them to adapt to their environment more quickly.
Researchers have developed a new classification system for Rickettsia bacteria, highlighting the importance of plasmids in virulence traits and host recognition. The study provides insight into the evolutionary origin of rickettsiae and has implications for the development of diagnostics and vaccines.
Researchers at the University of Arizona have discovered Mycobacterium Tuberculosis Pili (MTP), a virulence factor produced by tuberculosis bacteria during human infection. This finding suggests MTP could be a promising TB-vaccine candidate, addressing the need for more effective immunization strategies against this devastating disease.
Researchers are using solid-state NMR spectroscopy to explore the properties of natural antibiotics called antimicrobial peptides (AMPs), which are produced by virtually all animals. AMPs have shown promise in targeting microbes without harming healthy host cells.
Researchers found that bacteria like E. coli swim 'to the left' due to opposing forces of flow and bacterial motion, allowing them to find crevices and swim upstream. This phenomenon may contribute to high rates of infection in catheterized patients.
Researchers at Imperial College London have identified two key enzymes that help meningitis bacteria evade the body's immune system. The discovery could lead to novel treatments by disabling these enzymes and making the bacteria vulnerable to attack.
A dietary supplement called poly-hydroxybutyrate (PHB) has been found to protect brine shrimp from infection by antibiotic-resistant Vibrio campbellii bacteria. PHB is a naturally-occurring compound that can be produced on an industrial scale, offering a potential alternative to antibiotics in the fish farming industry.
Studies by LA BioMed researchers found that close contacts of patients with CA-MRSA infection may be at higher risk of acquiring an infection. The findings suggest that CA-MRSA strains are more transmissible than traditional S. aureus strains, emphasizing the need for cautious treatment and contact isolation.
Researchers found new genetic information in Salmonella serovar Typhimurium DT104 that enables its survival and infection mechanism. The extra genetic characteristics make the pathogen stronger and more infectious.
Scientists have made significant discoveries about the energy-generating mechanisms of bacteria, specifically Vibrio cholerae. The study reveals that this pathogen uses a unique system involving the enzyme NQR to generate a sodium gradient, which powers essential cell functions like movement and flagellar rotation.
Researchers found that a key protein is crucial for pneumonic plague's development. Disabling this protein slows the deadly attack, potentially giving doctors time to administer antibiotics and save patients.
Researchers are developing novel antibacterial compounds targeting MRSA, a life-threatening drug-resistant infection. The new medicines block the ability of MRSA bacteria to divide and multiply, reducing resistance levels.
Researchers at Yale University have discovered how Campylobacter jejuni enters intestinal cells and avoids destruction. The bacteria creates its own intracellular network of vacuoles, diverting from the conventional endocytic pathway.
Researchers discovered a new type of DNA parasite that can increase the spread of antibiotic-resistant bacteria. The 'stealth' plasmid produces a protein that helps it survive and thrive in bacteria, making it harder to eradicate with antibiotics.
Researchers discovered that neutrophils can form web-like structures called NETs outside cells, composed of nucleic acid and enzymes that catch bacteria and kill them. This process is equally effective as devouring bacteria, showcasing the neutrophil's role in defense even after death.
Researchers at Purdue University have developed a new technique called desorption electrospray ionization (DESI) to rapidly detect and precisely identify bacteria. This method enables the analysis of living bacteria in under a minute, with high accuracy and specificity.
Researchers have developed pharmaceuticals that prevent E. coli from assembling pili, rendering it non-pathogenic and susceptible to elimination. This approach aims to slow the growth of antibiotic-resistant infections and minimize the development of resistance.
A recent study conducted by scientists from the Lawrence Berkeley National Laboratory found an innovative DNA test to catalog airborne microbes. The research revealed a diverse bacterial population in Texas cities, which could aid in bioterrorism surveillance and climate change tracking.
The GreeneChip device uses nearly 30,000 pieces of genetic material to identify pathogens in human fluid and tissue samples. This technology enables rapid and specific diagnosis of emerging infectious diseases, including a previously undiagnosed fatal case of malaria.
A new study by the University of Michigan found that the construction of new highways in rural Ecuador is linked to higher rates of diarrheal diseases and a breakdown of traditional social structures. The roads, which connect previously isolated villages, bring new people and bacteria, leading to increased infection rates.
Researchers have discovered a human protein that disrupts anthrax bacteria's iron scavenging system, potentially leading to new anti-anthrax drugs and diagnostic tools. The study found that siderocalin binds to bacillibactin, preventing it from capturing iron, while petrobactin is not bound by the protein.
A new edible coating composed of apple puree and oregano oil has shown promise in killing deadly E. coli bacteria while providing flavor enhancement to food. The coating's effectiveness was demonstrated through laboratory studies, which found it to be more concentrated and longer-lasting than conventional produce washes.
A new lab-on-a-chip technology can identify bacterial strains causing drug-resistant pneumonia in hours, cutting down the wait from days to hours. The technology also helps in developing new drugs and can test the efficacy of existing drugs on unknown strains.
A University of Illinois food scientist has discovered that certain solutions used by meat processors to extend shelf life actually do double duty as antimicrobial agents, killing E. coli 0157:H7. The study found that some shelf-life enhancers, such as sodium lactate and sodium diacetate, are effective at reducing bacteria growth.
Researchers have created a new smart anti-microbial treatment called STAMP that can selectively target and kill cavity-causing bacteria without harming good bacteria. The treatment uses a specific pheromone to locate the bacteria and an anti-microbial bomb to eliminate it, offering a promising approach to preventing tooth decay.
Researchers have successfully synthesized platensimycin, a new antibiotic that inhibits bacterial fatty acid biosynthesis and paralyzes Gram-positive bacterial strains. This breakthrough offers hope against multiresistant bacteria, including Staphylococcus aureus and Enterococcus faecium.
Scientists reanalyzed 151 New York State samples using MassTag PCR, identifying nine previously undiagnosed pathogens, including six viruses and three bacteria. The analysis found that rhinoviruses were a major cause of influenza-like illness in the state during 2004.
Researchers have discovered a way to sort through large numbers of bacterial gene sequences by testing them in caterpillars, allowing pinpointing of virulence genes. The new technique, Rapid Virulence Annotation (RVA), is helping bridge the knowledge gap in post-genomic era.
A study found that patients who stayed in rooms previously occupied by MRSA carriers were more likely to acquire the bacteria, with an increased risk of 4.5% compared to 2.8%. Similarly, VRE acquisition was linked to prior occupant contamination, highlighting the importance of effective cleaning practices.
Researchers have developed a laser-based technology that can rapidly detect and identify many types of bacteria, making it three times faster and one-tenth as expensive as current methods. A second innovation uses chlorine dioxide gas to kill pathogens on produce, offering a highly effective and efficient solution.
A failed experiment by University of Wisconsin-Madison bacteriologist Marcin Filutowicz led to the creation of a new biocontrol agent that destroys bacterial pathogens without triggering antibiotic resistance. The discovery has started a promising biotechnology firm, creating high-paying jobs for Wisconsin.
Two studies reveal that contaminated carrots are a source of Yersinia pseudotuberculosis infection, while exposure to antibiotic-treated poultry increases the risk of antibiotic-resistant gut bacteria. The findings highlight the need for improved food safety regulations and hygiene practices to prevent such outbreaks.
The risk of transfusion-transmitted infections has decreased significantly since 1984 due to improved blood-safety measures. However, emerging pathogens such as variant Creutzfeldt-Jakob disease and viruses present in high concentrations in blood pose ongoing concerns for patient safety.
A new study reveals that the world's most widely used organic insecticide, Bacillus thuringiensis, requires the assistance of other microbes to perform its lethal work. The research demonstrates that the bacterium needs the presence of other bacteria in the insect gut to exert its influence.
Researchers at Rockefeller University have uncovered the mechanism by which Yersinia proteins disrupt host cell structure, killing their hosts. A mutation that impairs this process significantly reduces the bacteria's virulence, offering a potential target for new antibiotics.
In a study led by Johns Hopkins Medicine, researchers discovered that patients with chronic sinusitis who failed to respond to treatment had severely decreased immune function and lower production of key proteins. The findings suggest new treatment targets for this condition affecting an estimated 32 million Americans.
Researchers have developed a biodegradable wipe that can detect bacteria, viruses, and other biohazards using nanofibers containing antibodies. The new process could be used by anyone to rapidly uncover pathogens in contaminated areas, providing a fast indication of whether a biohazard is present.
Researchers at the University of Wisconsin-Madison have created 'conversation stoppers' that can block bacterial communication signals, offering a new approach to combat deadly bacterial infections. These small organic molecules can be combined with antibiotics to deliver a powerful one-two punch and minimize resistance development.
Researchers found that Yersinia bacteria harbor a protein called YpkA, which mimics an enzyme and blocks the host cell's ability to change shape and move. This discovery sheds new light on the factors that make Yersinia a deadly disease-causing agent.
Scientists have redefined the role of plant pores in defense against bacterial pathogens, discovering that stomata can sense danger and respond by shutting down. The study found that some bacteria produce a phytotoxin to reopen shut-down ports, highlighting a key step in the attack.
St. Jude researchers have solved a 25-year mystery by discovering the first biochemical step that many disease-causing bacteria use to build their membranes. The discovery holds promise for effective, new antibiotics against these bacteria, which would not cause dangerous side effects.
A new study found that removing deer from small areas can lead to increased tick populations and higher rates of tick-borne diseases. In contrast to previous studies, researchers discovered that smaller deer-free zones tend to harbor more ticks, making them potential disease hotspots.
A novel protein, RegIIIgamma, is produced by the intestinal lining to target and destroy bacterial invaders, offering insights into how the intestine maintains friendly relations with symbiotic microbes. The discovery may lead to new treatments for inflammatory bowel disease and improved understanding of probiotics.
Researchers developed a novel approach to assessing the risk of water-borne diseases, including leptospirosis, by measuring bacterial DNA in environmental waters. The method provides a quantitative risk assessment for human disease and has implications for health departments monitoring water safety.
A study by Penn State researchers found that breaks in hibernation may be an evolutionary mechanism to combat bacterial infections. Regular wake-ups help animals avoid serious infection while minimizing energy loss.
Researchers at Purdue University developed a new low-cost system that analyzes scattered laser light to quickly identify bacteria. The technique uses a petri dish containing bacterial colonies growing in a nutrient medium, projecting the scattered light pattern onto a screen behind the petri dish.
Researchers developed a vaccine using irradiated Listeria monocytogenes bacteria, providing better protection against disease than traditional heat-killed vaccines. The irradiated vaccine retained the ability to activate the immune system through Toll-like receptors, promoting long-term immunity.
Researchers developed a gamma-irradiated Listeria monocytogenes vaccine that elicits a strong T-cell response and protects against live challenge. The irradiated bacteria stimulate both adaptive and innate immune systems, providing a promising alternative to traditional vaccines.
A new study found a significant link between periodontal bacteria and the risk of heart disease, specifically acute coronary syndrome. The research suggests that specific bacteria, including T. denticola, T. forsythia, and streptococci spp, may contribute to inflammation and increased white blood cell counts.
Researchers from Michigan State University have uncovered a key bacterial protein that disables plant defense proteins, allowing bacteria to invade and destroy crops. This discovery has the potential to inform novel disease control strategies, particularly for human bacterial pathogens.
Researchers discovered that listeria bacteria first infect the placenta before using it as a breeding ground and then infecting other organs. The bacteria proliferate rapidly in the placenta before pouring out to cause infections.
Dr. Progulske-Fox received the Basic Research in Periodontal Disease Award for her work on P. gingivalis and its interactions with human cardiovascular cells. Her research aims to identify virulence genes that could lead to the development of new diagnostic tests, vaccines, and treatments for periodontal and cardiovascular diseases.
Dr. Marquis has been recognized with the IADR Research in Dental Caries Award for his groundbreaking work on fluoride's effects on bacterial metabolism and acid-base metabolism in dental plaque. His research has elucidated key mechanisms of acid tolerance and contributed to a better understanding of oral biofilms.
The overuse of antibiotics in fish farming can lead to increased bacterial resistance and disease risk. Consuming contaminated fish products can transfer these resistant bacteria to humans, posing a significant health threat.
The global MRSA problem is escalating, with increasing rates in Scandinavian countries and the Netherlands. The authors warn of the threat of community-acquired MRSA, which can evolve into 'fitter' strains combining antimicrobial resistance with transmissibility and virulence.
Researchers at Harvard Medical School and Argonne National Laboratory have discovered a protein secretion system in Pseudomonas aeruginosa that plays a critical role in the infection of cystic fibrosis patients. The discovery provides evidence for a new treatment target, offering hope for combating this deadly disease.
Bacteria have a unique immune system called H-NS that protects against foreign DNA, but can also enable the expression of disease-causing genes. This discovery has major implications for the biotech industry, which uses bacteria to produce recombinant proteins.